Brookfield Corporation
NYSE:BNAsset Management
-$0.32 today
- Market cap
- $87.93B
- Beta
- 1.84
- P/E (TTM)
- 83.3
- EPS (TTM)
- $0.53
- Dividend yield
- 0.59%
Volume 2.78M
Average 5.35M
BN Sales of Investments
Cash received from selling or redeeming investments.
Brookfield CorporationNYSE: BN
Sales of Investments · Q2 FY2026 · quarter ended Jun 2026
Sales of investments growth accelerates
Q2 FY2026 sales of investments of $8.04B rose 36.3% year over year, ahead of the +17.6% change in trailing-twelve-month sales of investments. Sequentially, it rose 21.0% from the prior quarter.
Context
- Sales of investments amounted to 0.0% of revenue in FY2025, down 20.7 pp from a year earlier.
- Sales of investments increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +36.3% holds above the trailing-twelve-month pace of +17.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 17.79B | -49.0% |
| FY2023 | 2023-12-31 | 34.9B | +72.5% |
| FY2022 | 2022-12-31 | 20.23B | -8.7% |
| FY2021 | 2021-12-31 | 22.14B | — |
Sales of Investments vs competitors
How BN compares with its peers on the latest reported figures
- BN's LTM Jun 2026 sales of investments of $23B is the 3rd largest of the 8 companies compared; the peer median is $2.5B.
- Its year-over-year change of +17.6% is the 2nd highest of 5, against a peer median of +1.6%.
- Sales of investments amounts to 29.6% of revenue for BN, versus a peer median of 49.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $79.76B | — | +38.7% | 221.8% | |
| LTM Sep 2026 | $65.59B | -7.9% | +29.5% | 325.4% | |
| LTM Jun 2026 | $23B | +17.6% | — | 29.6% | |
| LTM Sep 2026 | $4.42B | +7.1% | -13.6% | 27.1% | |
| LTM Sep 2026 | $2.5B | +1513.7% | +441.9% | 71.2% | |
| LTM Jun 2026 | $337.69M | — | — | 5.3% | |
| LTM Jun 2026 | $89.62M | -3.9% | +219.1% | 3.0% | |
| LTM Sep 2026 | $0 | — | — | — | |
| Peer median (excluding BN) | $2.5B | +1.6% | +38.7% | 49.2% | |
Competitors are the stored peer set for BN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 3.93B | 1.97B | 1.15B | 610.22M | 1.33B |
| Depreciation & Amortization | 6.44B | 7.68B | 9.08B | 9.74B | 10.38B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (3.16B) | (3.1B) | (1.45B) | (4B) | 0 |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (3.16B) | (3.1B) | (1.45B) | (4B) | 0 |
| Other Non-Cash Items | 592.6M | 1.85B | (2.19B) | 860.51M | (11.71B) |
| Operating Cash Flow | 7.8B | 8.4B | 6.59B | 7.21B | 0 |
| Capital Expenditures | (6.82B) | (6.95B) | (8.22B) | (10.64B) | 0 |
| Acquisitions (Net) | (7.81B) | (18.62B) | (6.17B) | (2.5B) | 0 |
| Purchases of Investments | (26.48B) | (18.52B) | (21.26B) | (21.5B) | 0 |
| Sales of Investments | 22.14B | 20.23B | 34.9B | 17.79B | 0 |
| Other Investing Activities | 353.86M | (3.71B) | (1.85B) | (3.24B) | 0 |
| Investing Cash Flow | (18.62B) | (27.57B) | (2.59B) | (20.09B) | 0 |
| Debt Repayment | 25.32B | 34.02B | 9.45B | 27.06B | 0 |
| Common Stock Issued | 22.8M | 13.45M | 49.9M | 18.09M | 0 |
| Common Stock Repurchased | (364.76M) | (658.82M) | (657.85M) | (952.94M) | 0 |
| Dividends Paid | (1.49B) | (1.03B) | (602M) | (663M) | 0 |
| Other Financing Activities | (9.84B) | (11.58B) | (15.66B) | (8.5B) | 0 |
| Financing Cash Flow | 13.67B | 20.82B | (7.43B) | 16.97B | 0 |
| Effect of Forex Changes | (113.82M) | 61.77M | 216.08M | (206.56M) | 1.17B |
| Net Change in Cash | 2.74B | 1.71B | (3.22B) | 3.88B | 1.17B |
| Free Cash Flow | 984.26M | 1.45B | (1.63B) | (3.43B) | 0 |
Brookfield Corporation
NYSE:BN
Intrinsic Alpha fair value
Locked
Current Price
$39.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.